
The FDA’s new CBER Safety Council separates post-market biologics safety review from approvals, raising oversight for cell and gene therapy developers.
Computational fluid dynamics can be a valuable tool for analyzing the efficiencies and performances of process equipment, which can lead to potential cost savings.
almost 25 years ago
Using Earned-Value Analysis to Better Manage Projectsalmost 25 years ago
Microbial Bioburden on Oral Solid Dosage Formsalmost 25 years ago
Modernizing Pharmaceutical Manufacturingalmost 25 years ago
Outsourcing Outlook




